Summary:
Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Qualified Participants Must:
• Be diagnosed with Depression
•
Be on an antidepressant
•
Be between 18 and 64 years of age
Qualified Participants May Receive:
Study medication and compensation for time/travel